BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 6797869)

  • 21. Efficacy of low-dose GnRH analogue (Buserelin) in the treatment of hirsutism.
    Bertoli A; Fusco A; Magnani A; Marini MA; Di Daniele N; Gatti S; Lauro R
    Exp Clin Endocrinol Diabetes; 1995; 103(1):15-20. PubMed ID: 7621099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Response of luteinizing hormone from columns of dispersed rat pituitary cells to a highly potent analogue of luteinizing hormone releasing hormone.
    Yeo T; Grossman A; Belchetz P; Besser GM
    J Endocrinol; 1981 Oct; 91(1):33-41. PubMed ID: 6795293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intranasal LHRH agonist treatment for inhibition of ovulation in women: clinical aspects.
    Bergquist C; Nillius SJ; Wide L
    Clin Endocrinol (Oxf); 1982 Jul; 17(1):91-8. PubMed ID: 6811167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of chronic LHRH agonist treatment on the endometrium and ovaries of the stumptailed macaque.
    Kerr-Wilson RH; MacKenzie L; Fraser HM
    Contraception; 1981 Dec; 24(6):647-55. PubMed ID: 6799243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peptide contraception in women. Inhibition of ovulation by chronic intranasal LRH agonist therapy.
    Bergquist C; Nillius SJ; Wide L
    Ups J Med Sci; 1984; 89(2):99-106. PubMed ID: 6431676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Metabolic effects and general side effects in the treatment of endometriosis with an LHRH agonist].
    Cirkel U; Schweppe KW; Ochs H; Schneider HP
    Geburtshilfe Frauenheilkd; 1987 Mar; 47(3):154-7. PubMed ID: 3108065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclical breast pain and swelling in relation to differing patterns of suppression of ovarian activity with the luteinizing hormone-releasing hormone analogue buserelin acetate: case report.
    Magill P; Barlow D
    Fertil Steril; 1995 Jan; 63(1):193-5. PubMed ID: 7805912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hormonal function of the adrenal cortex in "medical castration" induced by prolonged infusion of luliberin agonists].
    Goncharova ND; Mkhitarova LA
    Probl Endokrinol (Mosk); 1993; 39(1):51-4. PubMed ID: 8058666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Controlled release of a GnRH agonist from a polyhydroxybutyric acid implant: reversible suppression of the menstrual cycle in the macaque.
    Fraser HM; Sandow J; Seidel HR; Lunn SF
    Acta Endocrinol (Copenh); 1989 Dec; 121(6):841-8. PubMed ID: 2514544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of an LHRH agonist, buserelin, in the long-term management of premenstrual syndromes.
    Bancroft J; Boyle H; Warner P; Fraser HM
    Clin Endocrinol (Oxf); 1987 Aug; 27(2):171-82. PubMed ID: 3117452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Variations of endometrial changes in anovulatory menstrual cycle (author's transl)].
    Bárdos A
    Bratisl Lek Listy; 1980 Mar; 73(3):315-23. PubMed ID: 7363127
    [No Abstract]   [Full Text] [Related]  

  • 32. A national survey of the complications of endometrial destruction for menstrual disorders: the MISTLETOE study.
    Sowter M; Lethaby A; Farquhar C
    Br J Obstet Gynaecol; 1998 Dec; 105(12):1341-2. PubMed ID: 9883940
    [No Abstract]   [Full Text] [Related]  

  • 33. Modifications of the human endometrial fine structure induced by low-dose progestogen therapy.
    Maruffo CA; Casavilla F; van Nynatten B; Perez V
    Fertil Steril; 1974 Sep; 25(9):778-87. PubMed ID: 4420477
    [No Abstract]   [Full Text] [Related]  

  • 34. [Long-term administration of Buserelin, an LH-RH analogue, and its influence on the menstrual cycle (author's transl)].
    Hardt W; Schmidt-gollwitzer M
    Contracept Fertil Sex (Paris); 1983 Jan; 11(1):17-23. PubMed ID: 12311954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic treatment with a LH-RH-agonist: a new contraceptive method?
    Schmidt-Gollwitzer M; Hardt W; Schmidt-Gollwitzer K; Nevinny-Stickel J
    Acta Eur Fertil; 1981 Sep; 12(3):275-6. PubMed ID: 6803498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Progress in the contraceptive use of the LH-RH agonist buserelin: intermittent medication with gestagen-induced withdrawal bleeding].
    Hardt W; Schmidt-Gollwitzer K; Nevinny-Stickel J; Schmidt-Gollwitzer M
    Geburtshilfe Frauenheilkd; 1982 Dec; 42(12):874-7. PubMed ID: 6819180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Endometrial biopsy in hormonal imbalance].
    Gompel C; Muller C
    Ann Pathol; 1983; 3(2):101-17. PubMed ID: 6347212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Luteinizing hormone releasing hormone analogues for contraception.
    Nillius SJ
    Clin Obstet Gynaecol; 1984 Dec; 11(3):551-72. PubMed ID: 6391776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The influence of long-term medication with the LH-RH analogue buserelin on the regulation of the menstrual cycle (author's transl)].
    Hardt W; Schmidt-Gollwitzer M; von der Ohe M; Nevinny-Stickel J
    Geburtshilfe Frauenheilkd; 1981 Nov; 41(11):791-6. PubMed ID: 6797869
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.